Terkko Navigator / Nature Reviews Cancer

Mutations and mechanisms of WNT pathway tumour suppressors in cancer

2-Oxoglutarate-dependent dioxygenases in cancer

RNA in cancer

Author Correction: From genes to drugs: targeted strategies for melanoma

Non-genetic mechanisms of therapeutic resistance in cancer

Metabolic benefits of mitochondrial DNA mutations

Cancer progression and the invisible phase of metastatic colonization

The evolving translational potential of small extracellular vesicles in cancer

Improving human cancer therapy through the evaluation of pet dogs

Compartmental reorganization suppresses tumours

Sexual dimorphism in cancer

Hyperinsulinaemia in cancer

Metabolic rivalry: circadian homeostasis and tumorigenesis

Metabolic ageing drives tumour progression

The epigenomics of sarcoma

Getting your daily iron intake

The hardiness of liquids

A compendium of mutational cancer driver genes

Cardiovascular disease and cancer communicate

The immune contexture and Immunoscore in cancer prognosis and therapeutic efficacy

Neutrophil diversity and plasticity in tumour progression and therapy

Closing in on cfDNA-based detection and diagnosis

A new dawn for eosinophils in the tumour microenvironment

Strands of evolution

In vivo functional screening for systems-level integrative cancer genomics

Metabolites going up in smoke

Metabolism of immune cells in cancer

Tumours disrupt the immune scenery

Integrating serine with tumour initiation

The cancer–natural killer cell immunity cycle

Bacterial residents

Germline control of anti-tumour immunity

Prostate carcinogenesis: inflammatory storms

Key steps for effective breast cancer prevention

Publisher Correction: Cancer disparities in war-torn and post-war regions

Emerging themes in cohesin cancer biology

COVID-19 impact on early career investigators: a call for action

Switching off MDSCs by targeting REL

Clone conflict

The dormant cancer cell life cycle

Cancer disparities in war-torn and post-war regions

Tumour predisposition and cancer syndromes as models to study gene–environment interactions

Zones of biosynthesis

Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis

p53: 800 million years of evolution and 40 years of discovery

Author Correction: From melanocytes to melanomas

Not the usual suspect

Catching cancer

Executable cancer models: successes and challenges

The duality of human oncoproteins: drivers of cancer and congenital disorders